After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
VYGR belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Voyager Therapeutics Inc is $216.86M. A total of 0.56 million shares were traded on the day, compared to an average of 362.83K shares.
In the most recent transaction, Carter Todd Alfred sold 3,305 shares of VYGR for 4.26 per share on Feb 20 ’25. After the transaction, the Chief Scientific Officer now owns 77,718 company shares. In a previous transaction on Feb 20 ’25, Sandrock Alfred sold 11,702 shares at 4.24 per share. VYGR shares that President and CEO owns now total 296,816.
Among the insiders who sold shares, Swartz Robin disposed of 3,894 shares on Feb 20 ’25 at a per-share price of $4.25. This resulted in the COO & CBO holding 98,397 shares of VYGR after the transaction. In another insider transaction, Sandrock Alfred bought 11,702 shares at $4.24 per share on Feb 20 ’25.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, VYGR has a high of $10.66 and a low of $3.80.
As of this writing, VYGR has an earnings estimate of -$0.44 per share for the current quarter. EPS was calculated based on a consensus of 8.0 estimates, with a high estimate of -$0.17 per share and a lower estimate of -$0.72.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. VYGR’s latest balance sheet shows that the firm has $132.54M in Cash & Short Term Investments as of fiscal 2021. There were $44.18M in debt and $50.98M in liabilities at the time. Its Book Value Per Share was $6.06, while its Total Shareholder’s Equity was $95.06M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VYGR is Buy with a score of 5.00.
